EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 27th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 27th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 24, 2015 (the “Effective Date”), by and between Warren L. DeSouza (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 27th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 27th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 24, 2015 (the “Effective Date”), by and between Stephen G. Dilly, M.B.B.S., Ph.D. (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 27th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 27th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 24, 2015 (the “Effective Date”), by and between Mary M. Rozenman, Ph.D. (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 27th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 27th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 24, 2015 (the “Effective Date”), by and between Howard V. Raff, Ph.D. (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 27th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 27th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 24, 2015 (the “Effective Date”), by and between Robert M. Elfont, M.D., Ph.D. (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 9th, 2014 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into as of June 6, 2014 (the “Effective Date”), by and between Michael Raab (“Executive”) and Ardelyx, Inc. (the “Company”).